172 related articles for article (PubMed ID: 26254381)
21. PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups.
Schmidt LH; Kümmel A; Görlich D; Mohr M; Bröckling S; Mikesch JH; Grünewald I; Marra A; Schultheis AM; Wardelmann E; Müller-Tidow C; Spieker T; Schliemann C; Berdel WE; Wiewrodt R; Hartmann W
PLoS One; 2015; 10(8):e0136023. PubMed ID: 26313362
[TBL] [Abstract][Full Text] [Related]
22. Pulmonary blastomas of childhood: histologic, immunohistochemical, ultrastructural aspects and therapeutic considerations.
Boldrini R; Devito R; Diomedi-Camassei F; Francalanci P; Inserra A; Boglino C; Donfrancesco A; Jenkner A; Callea F
Ultrastruct Pathol; 2005; 29(6):493-501. PubMed ID: 16316950
[TBL] [Abstract][Full Text] [Related]
23. Classic biphasic pulmonary blastoma: A case report and review of the literature from 2000 to 2022.
Yao H; Jiang X; Zeng Y; Wang X; Tang X
Clin Respir J; 2023 Nov; 17(11):1103-1116. PubMed ID: 37772674
[TBL] [Abstract][Full Text] [Related]
24. Programmed death-1 ligand 1 and 2 are highly expressed in pleomorphic carcinomas of the lung: Comparison of sarcomatous and carcinomatous areas.
Kim S; Kim MY; Koh J; Go H; Lee DS; Jeon YK; Chung DH
Eur J Cancer; 2015 Nov; 51(17):2698-707. PubMed ID: 26329973
[TBL] [Abstract][Full Text] [Related]
25. ROS1-rearranged high-PD-L1-expressing lung adenocarcinoma manifesting as mediastinal tumor: A case report.
Ogawa H; Tanaka Y; Tachihara M; Uehara K; Shimizu N; Doi T; Hokka D; Maniwa Y
Oncol Lett; 2019 Jan; 17(1):488-491. PubMed ID: 30655791
[TBL] [Abstract][Full Text] [Related]
26. Biphasic pulmonary blastoma with germ cell differentiation in a 36-year-old man.
Archie PH; Beasley MB; Ross HJ
J Thorac Oncol; 2008 Oct; 3(10):1185-7. PubMed ID: 18827617
[TBL] [Abstract][Full Text] [Related]
27. A patient with classic biphasic pulmonary blastoma harboring
Meng Z; Chen P; Zang F; Liu Y; Xu X; Su Y; Chen J; Lin L; Zhang L; Zhang T
Onco Targets Ther; 2018; 11():157-161. PubMed ID: 29343973
[TBL] [Abstract][Full Text] [Related]
28. PD-1/PD-L1 pathway in non-small-cell lung cancer and its relation with EGFR mutation.
Ji M; Liu Y; Li Q; Li XD; Zhao WQ; Zhang H; Zhang X; Jiang JT; Wu CP
J Transl Med; 2015 Jan; 13():5. PubMed ID: 25592115
[TBL] [Abstract][Full Text] [Related]
29. Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation.
Chen N; Fang W; Zhan J; Hong S; Tang Y; Kang S; Zhang Y; He X; Zhou T; Qin T; Huang Y; Yi X; Zhang L
J Thorac Oncol; 2015 Jun; 10(6):910-23. PubMed ID: 25658629
[TBL] [Abstract][Full Text] [Related]
30. Classic biphasic pulmonary blastoma: a case report and review of the literature.
Luo Z; Cao C; Xu N; Ying K
J Int Med Res; 2020 Oct; 48(10):300060520962394. PubMed ID: 33107372
[TBL] [Abstract][Full Text] [Related]
31. Classic biphasic pulmonary blastoma with brain and axillary metastases: a case report with molecular analysis and review of literature.
Xiu Y; Jiang L; Liu W
Int J Clin Exp Pathol; 2015; 8(1):983-8. PubMed ID: 25755806
[TBL] [Abstract][Full Text] [Related]
32. Pulmonary blastoma: a case report and review of the literature.
Smyth RJ; Fabre A; Dodd JD; Bartosik W; Gallagher CG; McKone EF
BMC Res Notes; 2014 May; 7():294. PubMed ID: 24885892
[TBL] [Abstract][Full Text] [Related]
33. PD-L1 expression in small cell neuroendocrine carcinomas.
Schultheis AM; Scheel AH; Ozretić L; George J; Thomas RK; Hagemann T; Zander T; Wolf J; Buettner R
Eur J Cancer; 2015 Feb; 51(3):421-6. PubMed ID: 25582496
[TBL] [Abstract][Full Text] [Related]
34. Pulmonary blastoma in a young adult.
Agrawal D; Lahiri TK; Lakhotia S; Gupta G
Indian J Chest Dis Allied Sci; 2012; 54(3):189-92. PubMed ID: 23008928
[TBL] [Abstract][Full Text] [Related]
35. [Pulmonary blastoma--long-term survival of a patient with metastases].
Suzuki I; Oho K; Nakayama S; Tamura K; Tsuboi M; Okitsu H
Nihon Kyobu Geka Gakkai Zasshi; 1994 Aug; 42(8):1208-13. PubMed ID: 7963837
[TBL] [Abstract][Full Text] [Related]
36. [Pleuropulmonary blastoma: possible interest of neoadjuvant chemotherapy. A case report].
Regragui A; Cherradi N; Sefiani S; Malihy A; Khattab M; Alhamany Z
Rev Pneumol Clin; 2003 Dec; 59(6):365-70. PubMed ID: 14745343
[TBL] [Abstract][Full Text] [Related]
37. Pulmonary blastoma with renal metastasis responds to sorafenib.
Mulamalla K; Truskinovsky AM; Dudek AZ
J Thorac Oncol; 2007 Apr; 2(4):344-7. PubMed ID: 17409808
[TBL] [Abstract][Full Text] [Related]
38. Pleuropulmonary blastoma: an aggressive intrathoracic neoplasm of childhood.
Perdikogianni C; Stiakaki E; Danilatou V; Delides G; Kalmanti M
Pediatr Hematol Oncol; 2001 Jun; 18(4):259-66. PubMed ID: 11400650
[TBL] [Abstract][Full Text] [Related]
39. Aggressive multimodal treatment of pleuropulmonary blastoma.
Parsons SK; Fishman SJ; Hoorntje LE; Jaramillo D; Marcus KC; Perez-Atayde AR; Kozakewich HP; Grier HE; Shamberger RC
Ann Thorac Surg; 2001 Sep; 72(3):939-42. PubMed ID: 11565696
[TBL] [Abstract][Full Text] [Related]
40. Classic biphasic pulmonary blastoma demonstrated by 18F-FDG PET/CT.
Keu KV; Berry GJ; Quon A
Clin Nucl Med; 2014 Apr; 39(4):346-8. PubMed ID: 23989445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
